Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | matrix metallopeptidase-9 (M10 family) | 0.0082 | 0.0044 | 0.0085 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0867 | 0.2571 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.008 | 0.0036 | 0.002 |
Schistosoma mansoni | lipoxygenase | 0.0137 | 0.0219 | 0.1409 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0125 | 0.0181 | 0.0145 |
Leishmania major | telomerase reverse transcriptase, putative | 0.0867 | 0.2571 | 1 |
Loa Loa (eye worm) | matrixin family protein | 0.0125 | 0.0181 | 0.3413 |
Schistosoma mansoni | lipoxygenase | 0.0095 | 0.0087 | 0.0409 |
Brugia malayi | Probable 3',5'-cyclic phosphodiesterase T04D3.3, putative | 0.0233 | 0.0531 | 0.0736 |
Brugia malayi | Matrixin family protein | 0.0136 | 0.0217 | 0.0302 |
Echinococcus granulosus | calcium:calmodulin dependent 3'5' cyclic | 0.0109 | 0.0132 | 0.073 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0204 | 0.0438 | 0.3049 |
Schistosoma mansoni | tyrosine kinase | 0.0148 | 0.0256 | 0.1688 |
Echinococcus granulosus | calcium:calmodulin dependent 3'5' cyclic | 0.0233 | 0.0531 | 0.3752 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0068 | 0 | 0.5 |
Schistosoma mansoni | calcium/calmodulin-dependent 35-cyclic nucleotide phosphodiesterase | 0.0233 | 0.0531 | 0.3765 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0068 | 0 | 0.5 |
Loa Loa (eye worm) | PDE1B protein | 0.0233 | 0.0531 | 1 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0148 | 0.0256 | 0.1671 |
Echinococcus granulosus | high affinity cgmp specific 3' 5' cyclic | 0.0489 | 0.1356 | 1 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0204 | 0.0438 | 0.3049 |
Schistosoma mansoni | high-affinity cgmp-specific 35-cyclic phosphodiesterase | 0.0489 | 0.1356 | 1 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0489 | 0.1356 | 0.5018 |
Brugia malayi | Hemopexin family protein | 0.008 | 0.0036 | 0.005 |
Schistosoma mansoni | tyrosine kinase | 0.008 | 0.0036 | 0.002 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0137 | 0.0219 | 0.1392 |
Schistosoma mansoni | hypothetical protein | 0.008 | 0.0036 | 0.0025 |
Mycobacterium ulcerans | hydrolase | 0.0068 | 0 | 0.5 |
Toxoplasma gondii | RNA-directed DNA polymerase | 0.0867 | 0.2571 | 1 |
Giardia lamblia | Telomerase catalytic subunit | 0.0867 | 0.2571 | 0.5 |
Trypanosoma brucei | telomerase reverse transcriptase | 0.0867 | 0.2571 | 1 |
Plasmodium vivax | telomerase reverse transcriptase, putative | 0.0867 | 0.2571 | 1 |
Plasmodium falciparum | telomerase reverse transcriptase | 0.0867 | 0.2571 | 1 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0867 | 0.2571 | 1 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0148 | 0.0256 | 0.1671 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0148 | 0.0256 | 0.0355 |
Echinococcus multilocularis | high affinity cgmp specific 3' 5' cyclic | 0.0489 | 0.1356 | 1 |
Brugia malayi | Telomerase reverse transcriptase | 0.2306 | 0.7208 | 1 |
Onchocerca volvulus | Matrilysin homolog | 0.0125 | 0.0181 | 0.0145 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0148 | 0.0256 | 0.4826 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0137 | 0.0219 | 0.1392 |
Echinococcus multilocularis | calcium:calmodulin dependent 3',5' cyclic | 0.0109 | 0.0132 | 0.073 |
Loa Loa (eye worm) | matrixin family protein | 0.0136 | 0.0217 | 0.4095 |
Echinococcus multilocularis | calcium:calmodulin dependent 3',5' cyclic | 0.0233 | 0.0531 | 0.3752 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
SP (functional) | = 13.6 % | Evaluated in vitro for percent agonist activity in guinea pig ileum (substance P receptor) | ChEMBL. | 2433442 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.